DocSym
β
Searchsearch
Search
(L90.1) Anetoderma of schweninger-buzzi
More details coming soon
314 686 in individuals diagnosis anetoderma of schweninger-buzzi confirmed
Diagnosis anetoderma of schweninger-buzzi is diagnosed Women are 39.31% more likely than Men
95 498
Men receive the diagnosis anetoderma of schweninger-buzzi
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
219 188
Women receive the diagnosis anetoderma of schweninger-buzzi
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease anetoderma of schweninger-buzzi - Men aged 25-29 and Women aged 55-59
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+Less common in women the disease occurs at Age 95+
In Women diagnosis is most often set at age 0-94
Disease Features anetoderma of schweninger-buzzi
Absence or low individual and public risk
Anetoderma of schweninger-buzzi - what does this mean
Anetoderma of schweninger-buzzi is a rare skin disorder characterized by the formation of multiple, flat, round, atrophic patches on the skin. it is caused by the degeneration of the elastic fibers in the dermis, leading to the loss of skin elasticity and the formation of these patches.
What happens during the disease - anetoderma of schweninger-buzzi
Anetoderma of schweninger-buzzi is a rare and chronic skin disorder characterized by localized, flat-topped, soft, atrophic skin lesions. it is thought to be caused by a combination of an immune-mediated reaction and a defect in the structure and/or function of the dermal connective tissue. the immune-mediated reaction is thought to cause an inflammatory response that damages the dermal connective tissue, leading to a decrease in collagen and elastic fibers. this results in a loss of dermal elasticity and the formation of the atrophic skin lesions characteristic of anetoderma of schweninger-buzzi.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Histological examination of a skin biopsy
- Direct immunofluorescence
- Indirect immunofluorescence
- Serological tests
- Ultrasound
- Magnetic resonance imaging
- Electron microscopy
- X-ray
Treatment and Medical Assistance
Main goal of the treatment: To reduce the size of the lesions, restore skin integrity and improve the appearance of the skin.
- Topical corticosteroid therapy
- Systemic corticosteroid therapy
- Phototherapy
- Immunomodulatory therapy
- Surgical excision
- Intralesional injection of triamcinolone acetonide
- Cryotherapy
- Topical retinoids
- Topical tacrolimus
- Topical calcineurin inhibitors
- Topical antibiotics
- Systemic antibiotics
- Topical antifungal agents
- Systemic antifungal agents
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Anetoderma of schweninger-buzzi - Prevention
Anetoderma of schweninger-buzzi is best prevented by avoiding any kind of contact with the causative agent, which is usually a fungal infection. additionally, keeping the skin clean and dry, wearing loose-fitting clothing, and avoiding tight-fitting clothing or jewelry may help to reduce the risk of developing this condition.